Riesgo de enfermedad tromboembólica venosa y profilaxis antitrombótica en los pacientes ingresados en hospitales españoles (estudio ENDORSE)
Nieto Rodríguez, José Antonio.
Med. clín (Ed. impr.)
; 133(1): 1-7, jun. 2009. tab, graf, ilus
Artículo en Español | IBECS (España) | ID: ibc-73192
Documentos relacionados
Aspirin is as effective as low molecular weight heparins in preventing symptomatic venous thromboembolism following arthroscopic anterior cruciate ligament reconstruction.
Timing and Type of Venous Thromboembolic Prophylaxis in Isolated Severe Liver Injury Managed Non-Operatively.
Venous thromboembolism and prophylaxis therapy after elective spine surgery: a population-based study.
Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis.
Thromboembolic prophylaxis in neurosurgical practice: a systematic review.
Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.
Sequential low molecular weight heparin and rivaroxaban for venous thromboprophylaxis in pelvic and acetabular trauma.
[Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients].
Venous Thromboembolism Chemoprophylaxis in Trauma and Emergency General Surgery Patients: A Systematic Review.
Electronic prescribing systems as tools to improve patient care: a learning health systems approach to increase guideline concordant prescribing for venous thromboembolism prevention.